Back to Results
First PageMeta Content
Organic chemistry / Selective serotonin reuptake inhibitors / Psychiatry / Eli Lilly and Company / Organofluorides / Obsessive–compulsive disorder / Psilocybin / Lysergic acid diethylamide / Hallucinogen / Entheogens / Chemistry / Novartis


Moreno et al. Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Francisco A. Moreno, M.D.; Christopher B. Wiegand, M.D.; E. Keolani Taitano, Ph.D.; and Pedro L. Delgado, M
Add to Reading List

Document Date: 2014-10-08 15:35:57


Open Document

File Size: 105,76 KB

Share Result on Facebook

City

San Francisco / Tucson / San Antonio / Neuroreport / Washington / DC / Point Richmond / Phoenix / Cambridge / Chicago / San Juan / /

Company

SPSS Inc / PHYSICIANS PRESS INC. / Eli Lilly / Systat Software Inc / Hanes / Rasmussen SA / Pfizer / Pearson / Wyeth / Cyberonics / AstraZeneca / PHYSICIANS POSTGRADUATE PRESS INC. / /

Country

Puerto Rico / United States / /

/

Event

Person Communication and Meetings / /

Facility

Arch Gen Psychiatry / American College of Neuropsychopharmacology / University of Arizona Human Subjects Committee / University of Arizona / College of Medicine / New York State Psychiatric Institute / Heffter Research Institute / University of Texas Health Sciences Center / University of Arizona Health Sciences Center / /

IndustryTerm

treatment of obsessive-compulsive disorder / pharmaceutical / software programs / Internet postings / Treatment of Obsessive Compulsive Disorder / /

MedicalCondition

Chronic use / dysfunction / overall obsessive-compulsive symptom severity / bsessive-compulsive disorder / dysmorphic disorder / obsessivecompulsive disorder / chronic and debilitating condition / MS / Patients With Obsessive-Compulsive Disorder Francisco A. Moreno / Mental Disorders / I Disorders / R psychiatric disorders / obsessive compulsive disorder / disease / obsessive-compulsive symptoms / psychiatric disorder / psychiatric disorders / Diseases / depression / experienced transient hypertension / Injuries / obsessive-compulsive disorder / /

MedicalTreatment

brain surgery / psychotherapy / polypharmacy / /

Organization

Department of Psychiatry / Society of Biological Psychiatry / World Health Organization / Human Subjects Committee / University of Arizona Health Sciences Center / University of Texas Health Sciences Center / Multidisciplinary Association for Psychedelic Studies / Yale / Nathan Cummings Foundation / Harvard School of Public Health / Heffter Research Institute / American Psychiatric Association / World Bank / University of Arizona Human Subjects Committee / U.S. Food and Drug Administration / the American College / Psychiatric Institute / Arizona Hispanic Center of Excellence / College of Medicine / University of Arizona / New Clinical Drug Evaluation Unit / /

Person

Marcy Watchman / Ron Wright / George Greer / E. Keolani Taitano / Pedro L. Delgado / Torsten Passie / Jean McCreedy / Michael Mithoefer / Pierre Fabre / John Halpern / Rick Doblin / Francisco A. Moreno / Peggy Hitchcock / Stanislav Grof / Roberta Friedman Cummings / Christopher B. Wiegand / /

Position

principal investigator / consultant / Corresponding author / /

Product

Prozac / Wellbutrin / fluoxetine / Anafranil / Norpramin / /

ProvinceOrState

Texas / Maryland / New York / Manitoba / California / Arizona / /

PublishedMedium

Neuropsychopharmacology / /

Technology

gene expression / /

SocialTag